Interestingly, in patients with rheumatoid arthritis and CKD the use of anti-TNF therapies was associated with slower loss of GFR, although it is unclear whether this is the result of interfering with rheumatoid arthritis disease activity or with CKD-associated progression of kidney injury [41]. Here, TNF is linked to chronic kidney disease.